Orlando, FL -- (SBWIRE) -- 08/27/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Lightinthebox Holding Co Ltd-ADR(NYSE:LITB), E Commerce China Dangdang Inc (ADR)(NYSE:DANG).
Lightinthebox Holding Co Ltd-ADR(NYSE:LITB) saw the highest decline amongst Chinese online retailers as the firm gave a forecast of fall in third-quarter sales after disappointing revenues.
Should Investors Buy LITB After Yesterday’s Slump? Find Out Here
The firm’s stocks fell by 40 percent even as volumes increased. Online bookseller China Dangdang was also down whereas web fashion retailer Vipshop Holdings was down for the first time in a few days. On the other hand, Game operator Perfect World fell the most since March due to lower-than-estimated earnings.
LightInTheBox, based out of Beijing, sells lifestyle goods to markets abroad and had second-quarter revenue of $72.2 million. Credit Suisse Group AG lowered the firm’s rating.
Eric Block, portfolio manager at Clough Capital Partners opined that the firm missed the top line and there was a decline in quarterly growth which was unexpected.
The iShares China Large-Cap ETF, largest Chinese exhcnage-traded fund, was down by 1.4 percent to hit weekly low of $35.57.
LightInTheBox’s stocks are down to $11.58, the highest fall from June. The firm has estimated sales to be between $68-70 million for the quarter three, which are lower than last three months.
Beijing-based E Commerce China Dangdang Inc (ADR)(NYSE:DANG), China’s biggest web bookseller was down by 7.7 percent to $8.46 even though Dangdang’s despositary receipts have surged by 104 percent this year.
How Should Investors Trade DANG After The Recent Volatility? Get Free Report Here
Vipshop was down by 4.3 percent to $41.37 whereas Perfect World was down by7.9 percent to $18.99.
NeoGenomics, leading provider of cancer-focused genetic testing services, has said that it has launched a number of molecular tests for comprehensive profiling of myelodysplastic syndrome.
MDS is a difficult to diagnose disease with a number of clinical behaviors. The disease management can vary depending on the severity. NeoGenomics' comprehensive MDS testing covers every pertinent mutations connected to the disease. The company’s CEO and Chairman opined that the firm is committed to being the leading laboratory in molecular pathology.
The disease is diagnosed in over 10,000 people in the United States annually.
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
Disclosure: HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)